Related Experiment Video

Updated: Aug 6, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

TCR Diversity Underpins Immunotherapy Success

    Cancer Discovery
    |March 20, 2023
    PubMed

    Insights

    A diverse T cell response against cancer targets drives successful immune checkpoint blockade in melanoma. This finding can guide the development of new cancer vaccines and cell therapies.

    Area of Science:

    • Immunology
    • Oncology
    • Cancer Research

    Background:

    • Immune checkpoint blockade (ICB) therapy has shown promise in treating metastatic melanoma.
    • Understanding the T cell repertoire is crucial for optimizing ICB efficacy.

    Purpose of the Study:

    • To investigate the characteristics of T cell responses associated with successful ICB in metastatic melanoma.
    • To identify key cancer-specific targets that elicit effective anti-tumor immunity.

    Main Methods:

    • Analysis of T cell repertoire diversity in patients with metastatic melanoma undergoing ICB.
    • Identification of neoantigens recognized by T cells during ICB treatment.

    Main Results:

    • A diverse repertoire of T cells targeting a limited set of cancer-specific neoantigens is associated with ICB success.
    • The breadth and specificity of the T cell response correlate with clinical outcomes.

    Conclusions:

    • The diversity of T cell responses against specific cancer targets is critical for effective immune checkpoint blockade in metastatic melanoma.
    • These findings can inform the design of novel neoantigen-specific vaccines and adoptive T cell therapies for melanoma treatment.

    More Related Videos

    In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function08:04

    In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

    Published on: February 27, 2019

    11.8K
    A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

    A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

    Published on: October 16, 2018

    14.8K

    Related Concept Videos

    Diversity of Antigen Receptors01:28

    Diversity of Antigen Receptors

    Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
    Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
    700
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    601
    T Cell Activation and Clonal Selection01:22

    T Cell Activation and Clonal Selection

    T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
    Naive T cells that have not yet encountered an antigen express two primary CD...
    1.6K
    Cytotoxic T Cells-mediated Immune Response01:27

    Cytotoxic T Cells-mediated Immune Response

    Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
    Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
    1.1K
    Diversity in Cell Signaling Responses01:22

    Diversity in Cell Signaling Responses

    The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
    Graded and Abrupt Responses
    Some signaling systems generate...
    6.5K